From Carbon to Strategy: Why Integrate Climate into Your Investments?

Climate change is becoming increasingly important for institutional investors, not only because of regulatory change, but also because of the risks involved. But what are the measures of the climate footprint of investments? How can climate protection and decarbonization be integrated into institutional portfolios? And how are the characteristics and performance of these portfolios affected by climate-related considerations?

While investors are encouraged to consider climate change in their portfolios, to meet regulatory requirements and mitigate climate-related risks, a number of questions remain:

  • How can you measure the carbon footprint of your portfolio, and the impact of climate change on your investments?
  • Since the Paris Agreement, what regulations now govern institutional sustainable investment policies?
  • How can climate considerations influence investment strategies?

In this paper, we propose that insurers and pension funds answer these questions through case studies and measurements of financial and sustainable impact.

;
Fabrice Sauzeau - Gert De Maeyer
Deputy Head of Pension and Insurance Relations and Development
Indicators such as the carbon footprint are not enough to answer the complex question of the impact and risks of climate change.

Want to know more about the impact and risks of climate change ?

Download our white paper.

Latest analyses

  • ESG, SRI, Oncology

    From uncertainty to growth: why invest in healthcare?

    As we enter the month of October, investors are faced with an obvious question: is the time right for new investments in the oncology sector? Pasquale Sansone, Senior Biotechnology Analyst, shares his analysis and convictions.
  • Ken Van Weyenberg, Oncology, ESG, SRI

    Why oncology remains a key investment opportunity

    The investment landscape is marked by persistent macroeconomic uncertainties, uneven growth, and heightened geopolitical risks. Despite attractive earnings growth, healthcare has also been under pressure due to regulatory restructuring, drug pricing debates, budget constraints, and tariff concerns.
  • Research Paper, Climate Action, ESG, SRI, Alix Chosson

    Net Zero Progress Report

    We promised you transparency. For a comprehensive discussion of our efforts and results, see our [annual] Net Zero Progress Report 2024. We frequently say that it is not just the carbon target, but the path to that target which affects the damage along the way. In this spirit, we share with you along the way our milestones for the four pillars of our Net Zero strategy.
  • ESG, SRI

    Active Ownership: Persistence Pays

    If some elements of our annual 2024 Annual Engagement and Voting Review sound familiar, that’s no coincidence. To maximize our impact, we focus on long-term core topics. Engagement and voting are central to our investment process, extending beyond the important responsibility of the investments we already hold.
  • Research Paper, Marie Niemczyk, Jorick Liebrand, ESG, SRI, AI

    AI Through the ESG Lens: Tackling Risks and Opportunities

    Is the Artificial Intelligence (AI) revolution unstoppable? With lightning speed, AI is reshaping industries, unlocking economic value, driving positive environmental impact, helping address social challenges – and additionally, offering compelling investment opportunities.
  • Once upon a time, mankind invented PFAS (per- and polyfluoroalkyl substances).
    Bastien Dublanc, Astrid Pierard, Jessica Carlier, ESG, SRI, Equities, Research Paper, Water

    PFAS: Genius gone wrong

    PFAS have been widely used for decades due to their unique properties in various domestic and industrial applications. They are resistant to water and virtually indestructible. They are also seen as the poison of the century. Where do we stand in terms of regulation? What are the PFAS-related risks? Where are the opportunities?

Find it fast

Get information faster with a single click

Get insights straight to your inbox